Skip to main content

The Role of Sphingolipids in Neuronal Development: Lessons from Models of Sphingolipid Storage Diseases

Neurochemical Research volume 27, pages 565–574 (2002)Cite this article

Abstract

The study of sphingolipids has undergone a renaissance over the past decade due to the realization that these lipids are involved in a variety a biological processes, such as differentiation, apoptosis, cell growth, and cell migration. In the nervous system, sphingolipids, particularly gangliosides, have attracted particular attention as they occur at high levels and their levels change in a developmentally regulated program. Despite the fact that a large body of data has accumulated on the expression and metabolism of individual gangliosides within specific brain regions, the role of individual gangliosides in neuronal development is still poorly understood, and their specific functions are only now beginning to be elucidated. In the present article, we discuss various aspects of our current knowledge concerning the involvement of sphingolipids and gangliosides in neuronal development, and then discuss some recent findings that shed light on the role of sphingolipids and gangliosides obtained with animal models of sphingolipid and other lysosomal storage diseases.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

REFERENCES

  1. Perry, D. K. and Hannun, Y. A. 1998. The role of ceramide in cell signaling. Biochim. Biophys. Acta 1436:233-243.

    Google Scholar 

  2. Riboni, L., Viani, P., Bassi, R., Prinetti, A., and Tettamanti, G. 1997. The role of sphingolipids in the process of signal transduction. Prog. Lipid Res. 36:153-195.

    Google Scholar 

  3. Ando, S. 1983. Gangliosides in the nervous system. Neurochem. Int. 5:507-537.

    Google Scholar 

  4. Yu, R. K. and Saito, M. 1989. Structure and Localization of Gangliosides. Pages 174-187, in Margolis, R. U., and Margolis, R. K. (Eds.), Neurobiology of Glycoconjugates, Plenum, New York.

    Google Scholar 

  5. Ledeen, R. W. and Yu, G. 1992. Ganglioside function in the neuron. Trends Glycosci. Glycotechnol. 4:174-187.

    Google Scholar 

  6. Schwarz, A. and Futerman, A. H. 1996. The localization of gangliosides in neurons of the central nervous system: the use of anti-ganglioside antibodies. Biochim. Biophys. Acta 1286:247-267.

    Google Scholar 

  7. Facci, L., Leon, A., Toffano, G., Sonnino, S., Ghidoni, R., and Tettamanti, G. 1984. Promotion of neuritogenesis in mouse neuroblastoma cells by exogenous gangliosides. Relationship between the effect and the cell association of ganglioside GM1. J. Neurochem. 42:299-305.

    Google Scholar 

  8. Walkley, S. U., Siegel, D. A., Dobrenis, K., and Zervas, M. 1998. GM2 ganglioside as a regulator of pyramidal neuron dendritogenesis. Ann. N.Y. Acad. Sci. 845:188-199.

    Google Scholar 

  9. Walkley, S. U., Zervas, M., and Wiseman, S. 2000. Gangliosides as modulators of dendritogenesis in normal and storage disease-affected pyramidal neurons. Cereb. Cortex 10:1028-1037.

    Google Scholar 

  10. Leon, A., Facci, L., Toffano, G., Sonnino, S., and Tettamanti, G. 1981. Activation of (Na+, K+)-ATPase by nanomolar concentrations of GM1 ganglioside. J. Neurochem. 37:350-357.

    Google Scholar 

  11. Bassi, R., Chigorno, V., Fiorilli, A., Sonnino, S., and Tettamanti, G. 1991. Exogenous gangliosides GD1b and GD1blactone, stably associated to rat brain P2 subcellular fraction, modulate differently the process of protein phosphorylation. J. Neurochem. 57:1207-1211.

    Google Scholar 

  12. Hakomori, S. 1990. Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J. Biol. Chem. 265:18713-18716.

    Google Scholar 

  13. Schnaar, R. L. 1991. Glycosphingolipids in cell surface recognition. Glycobiology 1:477-485.

    Google Scholar 

  14. Dotti, C. G., Sullivan, C. A., and Banker, G. A. 1988. The establishment of polarity by hippocampal neurons in culture. J. Neurosci. 8:1454-1468.

    Google Scholar 

  15. Goslin, K., Asmussen, H., and Banker, G. (1998) Pages 339-370, in Banker, G., and Goslin, K. (eds), Culturing Nerve Cells, MIT press, Cambridge, MA.

    Google Scholar 

  16. Futerman, A. H. 1998. The roles of ceramide in the regulation of neuronal growth and development. Biochemistry (Moscow) 63:74-83.

    Google Scholar 

  17. Futerman, A. H., Boldin, S., Brann, A. B., Schwarz, A., and Zisling, R. 1998. Regulatory roles for sphingolipids in the growth of polarized neurons. Ann. N. Y. Acad. Sci. 845:176-187.

    Google Scholar 

  18. Futerman, A. H. 1998. Distinct roles for sphingolipids and glycosphingolipids at different stages of neuronal development. Acta Biochim. Pol. 45:469-478.

    Google Scholar 

  19. Futerman, A. H., Boldin, S. A., Brann, A. B., Pelled, D., Meivar-Levy, I., and Zisling, R. 1999. Regulation of sphingolipid and glycosphingolipid metabolism during neuronal growth and development. Biochem. Soc. Trans. 27:432-437.

    Google Scholar 

  20. Svennerholm, L., Bostrom, K., Fredman, P., Mansson, J. E., Rosengren, B., and Rynmark, B. M. 1989. Human brain gangliosides: developmental changes from early fetal stage to advanced age. Biochim. Biophys. Acta 1005:109-117.

    Google Scholar 

  21. Hirabayashi, Y., Hyogo, A., Nakao, T., Tsuchiya, K., Suzuki, Y., Matsumoto, M., Kon, K., and Ando, S. 1990. Isolation and characterization of extremely minor gangliosides, GM1b and GD1 alpha, in adult bovine brains as developmentally regulated antigens. J. Biol. Chem. 265:8144-8151.

    Google Scholar 

  22. Sonnino, S., Bassi, R., Chigorno, V., and Tettamanti, G. 1990. Further studies on the changes of chicken brain gangliosides during prenatal and postnatal life. J. Neurochem. 54:1653-1660.

    Google Scholar 

  23. Rosner, H., al-Aqtum, M., and Rahmann, H. 1992. Gangliosides and neuronal differentiation. Neurochem. Int. 20:339-351.

    Google Scholar 

  24. Yu, R. K. 1994. Development regulation of ganglioside metabolism. Prog. Brain Res. 101:31-44.

    Google Scholar 

  25. Levine, J. M., Beasley, L., and Stallcup, W. B. 1984. The D1.1 antigen: a cell surface marker for germinal cells of the central nervous system. J. Neurosci. 4:820-831.

    Google Scholar 

  26. Mendez-Otero, R., Schlosshauer, B., Barnstable, C. J., and Constantine-Paton, M. 1988. A developmentally regulated antigen associated with neural cell and process migration. J. Neurosci. 8:564-579.

    Google Scholar 

  27. Kotani, M., Kawashima, I., Ozawa, H., Terashima, T., and Tai, T. 1993. Differential distribution of major gangliosides in rat central nervous system detected by specific monoclonal antibodies. Glycobiology 3:137-146.

    Google Scholar 

  28. Yu, R. K. and Ando, S. 1980. Structures of some new complex gangliosides of fish brain. Adv. Exp. Med. Biol. 125:33-45.

    Google Scholar 

  29. Rosner, H. 1982. Ganglioside changes in the chicken optic lobes as biochemical indicators of brain development and maturation. Brain Res. 236:49-61.

    Google Scholar 

  30. Yu, R. K., Macala, L. J., Taki, T., Weinfield, H. M., and Yu, F. S. 1988. Developmental changes in ganglioside composition and synthesis in embryonic rat brain. J. Neurochem. 50: 1825-1829.

    Google Scholar 

  31. Suzuki, K., Poduslo, S. E., and Norton, W. T. 1967. Gangliosides in the myelin fraction of developing rats. Biochim. Biophys. Acta 144:375-381.

    Google Scholar 

  32. Suzuki, K. 1970. Formation and turnover of myelin ganglioside. J. Neurochem. 17:209-213.

    Google Scholar 

  33. Saito, M. and Yu, R. K. 1992. Role of myelin-associated neuraminidase in the ganglioside metabolism of rat brain myelin. J. Neurochem. 58:83-87.

    Google Scholar 

  34. Saito, M., Tanaka, Y., Tang, C. P., Yu, R. K., and Ando, S. 1995. Characterization of sialidase activity in mouse synaptic plasma membranes and its age-related changes. J. Neurosci. Res. 40:401-406.

    Google Scholar 

  35. Banker, G. A. and Cowan, W. M. 1977. Brain Res. 126: 397-425.

    Google Scholar 

  36. Hirschberg, K., Zisling, R., van Echten-Deckert, G., and Futerman, A. H. 1996. Ganglioside synthesis during the development of neuronal polarity. Major changes occur during axonogenesis and axon elongation, but not during dendrite growth or synaptogenesis. J. Biol. Chem. 271:14876-14882.

    Google Scholar 

  37. Harel, R. and Futerman, A. H. 1993. Inhibition of sphingolipid synthesis affects axonal outgrowth in cultured hippocampal neurons. J. Biol. Chem. 268:14476-14481.

    Google Scholar 

  38. Schwarz, A., Rapaport, E., Hirschberg, K., and Futerman, A. H. 1995. A regulatory role for sphingolipids in neuronal growth. Inhibition of sphingolipid synthesis and degradation have opposite effects on axonal branching. J. Biol. Chem. 270:10990-10998.

    Google Scholar 

  39. Schwarz, A. and Futerman, A. H. 1997. Distinct roles for ceramide and glucosylceramide at different stages of neuronal growth. J. Neurosci. 17:2929-2938.

    Google Scholar 

  40. Takamiya, K., Yamamoto, A., Furukawa, K., Yamashiro, S., Shin, M., Okada, M., Fukumoto, S., Haraguchi, M., Takeda, N., Fujimura, K., Sakae, M., Kishikawa, M., Shiku, H., and Aizawa, S. 1996. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc. Natl. Acad. Sci. U. S. A. 93:10662-10667.

    Google Scholar 

  41. Takamiya, K., Yamamoto, A., Furukawa, K., Zhao, J., Fukumoto, S., Yamashiro, S., Okada, M., Haraguchi, M., Shin, M., Kishikawa, M., Shiku, H., and Aizawa, S. 1998. Complex gangliosides are essential in spermatogenesis of mice: possible roles in the transport of testosterone. Proc. Natl. Acad. Sci. U. S. A. 95:12147-12152.

    Google Scholar 

  42. Sheikh, K. A., Sun, J., Liu, Y., Kawai, H., Crawford, T. O., Proia, R. L., Griffin, J. W., and Schnaar, R. L. 1999. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc. Natl. Acad. Sci. U. S. A. 96:7532-7537.

    Google Scholar 

  43. Liu, Y., Hoffmann, A., Grinberg, A., Westphal, H., McDonald, M. P., Miller, K. M., Crawley, J. N., Sandhoff, K., Suzuki, K., and Proia, R. L. 1997. Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment. Proc. Natl. Acad. Sci. U. S. A. 94:8138-8143.

    Google Scholar 

  44. Sango, K., McDonald, M. P., Crawley, J. N., Mack, M. L., Tifft, C. J., Skop, E., Starr, C. M., Hoffmann, A., Sandhoff, K., Suzuki, K., and Proia, R. L. 1996. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Nat. Genet. 14:348-352.

    Google Scholar 

  45. Yamanaka, S., Johnson, M. D., Grinberg, A., Westphal, H., Crawley, J. N., Taniike, M., Suzuki, K., and Proia, R. L. 1994. Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Proc. Natl. Acad. Sci. U. S. A. 91:9975-9979.

    Google Scholar 

  46. Liu, Y., Suzuki, K., Reed, J. D., Grinberg, A., Westphal, H., Hoffmann, A., Doring, T., Sandhoff, K., and Proia, R. L. 1998. Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure. Proc. Natl. Acad. Sci. U. S. A. 95:2503-2508.

    Google Scholar 

  47. Yamashita, T., Wada, R., Sasaki, T., Deng, C., Bierfreund, U., Sandhoff, K., and Proia, R. L. 1999. A vital role for glycosphingolipid synthesis during development and differentiation. Proc. Natl. Acad. Sci. U. S. A. 96:9142-9147.

    Google Scholar 

  48. Mansson, J. E., Vanier, M. T., and Svennerholm, L. 1978. Changes in the fatty acid and sphingosine composition of the major gangliosides of human brain with age. J. Neurochem. 30:273-275.

    Google Scholar 

  49. Palestini, P., Sonnino, S., and Tettamanti, G. 1991. Lack of the ganglioside molecular species containing the C20-long-chain bases in human, rat, mouse, rabbit, cat, dog, and chicken brains during prenatal life. J. Neurochem. 56:2048-2050.

    Google Scholar 

  50. Valsecchi, M., Palestini, P., Chigomo, V., Sonnino, S., and Tettamanti, G. 1993. Changes in the ganglioside long-chain base composition of rat cerebellar granule cells during differentiation and aging in culture. J. Neurochem. 60:193-196.

    Google Scholar 

  51. Sonnino, S. and Chigorno, V. 2000. Ganglioside molecular species containing C18-and C20-sphingosine in mammalian nervous tissues and neuronal cell cultures. Biochim. Biophys. Acta 1469:63-77.

    Google Scholar 

  52. Valsecchi, M., Chigorno, V., Sonnino, S., and Tettamanti, G. 1992. Rat cerebellar granule cells in culture associate and metabolize differently exogenous GM1 ganglioside molecular species containing a C18 or C20 long chain base. Chem. Phys. Lipids 60:247-252.

    Google Scholar 

  53. Chigorno, V., Negroni, E., Nicolini, M., and Sonnino, S. 1997. Activity of 3-ketosphinganine synthase during differentiation and aging of neuronal cells in culture. J. Lipid Res. 38:1163-1169.

    Google Scholar 

  54. Boldin, S. and Futerman, A. H. 1997. Glucosylceramide synthesis is required for basic fibroblast growth factor and laminin to stimulate axonal growth. J. Neurochem. 68:882-885.

    Google Scholar 

  55. Brann, A. B., Tcherpakov, M., Williams, I. M., Futerman, A. H., and Fainzilber, M. 2002. NGF-induced p75-mediated death of cultured hippocampal neurons is age-dependent and transduced through ceramide generated by neutral sphingomyelinase. J. Biol. Chem. (in press).

  56. Brann, A. B., Scott, R., Neuberger, Y., Abulafia, D., Boldin, S., Fainzilber, M., and Futerman, A. H. 1999. Ceramide signaling downstream of the p75 neurotrophin receptor mediates the effects of nerve growth factor on outgrowth of cultured hippocampal neurons. J. Neurosci. 19:8199-8206.

    Google Scholar 

  57. Pelled, D., Raveh, T., Riebeling, C., Fridkin, M., Berissi, H., Futerman, A. H., and Kimchi, A. 2001. Death-protein-(DAP) kinase plays a central role in ceramide-induced apoptosis in cultured hippocampal neurons. J. Biol. Chem. 277:1957-1961.

    Google Scholar 

  58. Uemura, K., Sugiyama, E., and Taketomi, T. 1991. Effects of an inhibitor of glucosylceramide synthase on glycosphingolipid synthesis and neurite outgrowth in murine neuroblastoma cell lines. J. Biochem. (Tokyo) 110:96-102.

    Google Scholar 

  59. Furuya, S., Ono, K., and Hirabayashi, Y. 1995. Sphingolipid biosynthesis is necessary for dendrite growth and survival of cerebellar Purkinje cells in culture. J. Neurochem. 65:1551-1561.

    Google Scholar 

  60. Schwarz, A. and Futerman, A. H. 1998. Inhibition of sphingolipid synthesis, but not degradation, alters the rate of dendrite growth in cultured hippocampal neurons. Brain Res. Dev. Brain Res. 108:125-130.

    Google Scholar 

  61. Boldin, S. A. and Futerman, A. H. 2000. Up-regulation of glucosylceramide synthesis upon stimulation of axonal growth by basic fibroblast growth factor. Evidence for post-translational modification of glucosylceramide synthase. J. Biol. Chem. 275: 9905-9909.

    Google Scholar 

  62. Weinstein, D. C. and Hemmati-Brivanlou, A. 1999. Neural induction. Annu. Rev. Cell Dev. Biol. 15:411-433.

    Google Scholar 

  63. Radin, N. S. 1994. Rationales for cancer chemotherapy with PDMP, a specific inhibitor of glucosylceramide synthase. Mol. Chem. Neuropathol. 21:111-127.

    Google Scholar 

  64. Radin, N. S. 2001. Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come? Eur. J. Biochem. 268:193-204.

    Google Scholar 

  65. Sprong, H., Degroote, S., Claessens, T., van Drunen, J., Oorschot, V., Westerink, B. H., Hirabayashi, Y., Klumperman, J., van der Sluijs, P., and van Meer, G. 2001. Glycosphingolipids are required for sorting melanosomal proteins in the Golgi complex. J. Cell Biol. 155:369-380.

    Google Scholar 

  66. Korkotian, E., Schwarz, A., Pelled, D., Schwarzmann, G., Segal, M., and Futerman, A. H. 1999. Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons. J. Biol. Chem. 274:21673-21678.

    Google Scholar 

  67. Dawkins, J. L., Hulme, D. J., Brahmbhatt, S. B., Auer-Grumbach, M., and Nicholson, G. A. 2001. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat. Genet. 27:309-312.

    Google Scholar 

  68. Bejaoui, K., Wu, C., Scheffler, M. D., Haan, G., Ashby, P., Wu, L., de Jong, P., and Brown, R. H., Jr. 2001. SPTLC1 is mutated in hereditary sensory neuropathy, type 1. Nat. Genet. 27:261-262.

    Google Scholar 

  69. Walkley, S. U. 1988. Pathobiology of neuronal storage disease. Int. Rev. Neurobiol. 29:191-244.

    Google Scholar 

  70. Walkley, S. U., Baker, H. J., and Rattazzi, M. C. 1990. Initiation and growth of ectopic neurites and meganeurites during postnatal cortical development in ganglioside storage disease. Brain Res. Dev. Brain Res. 51:167-178.

    Google Scholar 

  71. Walkley, S. U., Wurzelmann, S., Rattazzi, M. C., and Baker, H. J. 1990. Distribution of ectopic neurite growth and other geometrical distortions of CNS neurons in feline GM2 gangliosidosis. Brain Res. 510:63-73.

    Google Scholar 

  72. Walkley, S. U. 1998. Cellular pathology of lysosomal storage disorders. Brain Pathol. 8:175-193.

    Google Scholar 

  73. Purpura, D. P. and Suzuki, K. 1976. Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease. Brain Res. 116:1-21.

    Google Scholar 

  74. Ledeen, R. W. 1984. Biology of gangliosides: neuritogenic and neuronotrophic properties. J. Neurosci. Res. 12:147-159.

    Google Scholar 

  75. Vanier, M. T. 1999. Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature. Neurochem. Res. 24:481-489.

    Google Scholar 

  76. Zervas, M., Dobrenis, K., and Walkley, S. U. 2001. Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J. Neuropathol. Exp. Neurol. 60:49-64.

    Google Scholar 

  77. Vogler, C., Barker, J., Sands, M. S., Levy, B., Galvin, N., and Sly, W. S. 2001. Murine mucopolysaccharidosis VIL: impact of therapies on the phenotype, clinical course, and pathology in a model of a lysosomal storage disease. Pediatr. Dev. Pathol. 4:421-433.

    Google Scholar 

  78. Kyle, J. W., Birkenmeier, E. H., Gwynn, B., Vogler, C., Hoppe, P. C., Hoffmann, J. W., and Sly, W. S. 1990. Correction of murine mucopolysaccharidosis VII by a human beta-glucuronidase transgene. Proc. Natl. Acad. Sci. U. S. A. 87:3914-1918.

    Google Scholar 

  79. Shull, R. M., Munger, R. J., Spellacy, E., Hall, C. W., Constantopoulos, G., and Neufeld, E. F. 1982. Canine alpha-Liduronidase deficiency. A model of mucopolysaccharidosis I. Am. J. Pathol. 109:244-248.

    Google Scholar 

  80. March, P. A., Thrall, M. A., Brown, D. E., Mitchell, T. W., Lowenthal, A. C., and Walkley, S. U. 1997. GABAergic neuroaxonal dystrophy and other cytopathological alterations in feline Niemann-Pick disease type C. Acta Neuropathol. (Berlin) 94:164-172.

    Google Scholar 

  81. Zervas, M., Somers, K. L., Thrall, M. A., and Walkley, S. U. 2001. Critical role for glycosphingolipids in Niemann-Pick disease type C. Curr. Biol. 11:1283-1287.

    Google Scholar 

  82. Liu, Y., Wu, Y. P., Wada, R., Neufeld, E. B., Mullin, K. A., Howard, A. C., Pentchev, P. G., Vanier, M. T., Suzuki, K., and Proia, R. L. 2000. Alleviation of neuronal ganglioside storage does not improve the clinical course of the Niemann-Pick C disease mouse. Hum. Mol. Genet. 9:1087-1092.

    Google Scholar 

  83. Liu, Y., Wada, R., Kawai, H., Sango, K., Deng, C., Tai, T., McDonald, M. P., Araujo, K., Crawley, J. N., Bierfreund, U., Sandhoff, K., Suzuki, K., and Proia, R. L. 1999. A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J. Clin. Invest. 103:497-505.

    Google Scholar 

  84. Nilsson, O. and Svennerholm, L. 1982. Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease. J. Neurochem. 39:709-718.

    Google Scholar 

  85. Orvisky, E., Sidransky, E., McKinney, C. E., Lamarca, M. E., Samimi, R., Krasnewich, D., Martin, B. M., and Ginns, E. I. 2000. Glucosylsphingosine accumulation in mice and patients with type 2 Gaucher disease begins early in gestation. Pediatr. Res. 48:233-237.

    Google Scholar 

  86. Kobayashi, T., Goto, I., Okada, S., Orii, T., Ohno, K., and Nakano, T. 1992. Accumulation of lysosphingolipids in tissues from patients with GM1 and GM2 gangliosidoses. J. Neurochem. 59:1452-1458.

    Google Scholar 

  87. Suzuki, K. 1988.Twenty five years of the "psychosine hypothesis": a personal perspective of its history and present status. Neurochem. Res. 23:251-259.

    Google Scholar 

  88. Atsumi, S., Nosaka, C., Iinuma, H., and Umezawa, K. 1993. Accumulation of tissue glucosylsphingosine in Gaucher-like mouse induced by the glucosylceramidase inhibitor cyclophellitol. Arch. Biochem. Biophys. 304:302-304.

    Google Scholar 

  89. Igisu, H., Hamasaki, N., Ito, A., and Ou, W. 1988. Inhibition of cytochrome c oxidase and hemolysis caused by lysosphingolipids. Lipids 23:345-348.

    Google Scholar 

  90. Hannun, Y. A. and Bell, R. M. 1987. Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science 235:670-674.

    Google Scholar 

  91. Sohal, P. S. and Cornell, R. B. 1990. Sphingosine inhibits the activity of rat liver CTP:phosphocholine cytidylyltransferase. J. Biol. Chem. 265:11746-11750.

    Google Scholar 

Download references

Author information

Affiliations

  1. Department of Biological Chemistry, Weizmann Institute of Science, 76100, Rehovot, Israel

    Rosaria Buccoliero, Jacques Bodennec & Anthony H. Futerman

Authors
  1. Rosaria Buccoliero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacques Bodennec
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anthony H. Futerman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Buccoliero, R., Bodennec, J. & Futerman, A.H. The Role of Sphingolipids in Neuronal Development: Lessons from Models of Sphingolipid Storage Diseases. Neurochem Res 27, 565–574 (2002). https://doi.org/10.1023/A:1020207613196

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020207613196

  • Hippocampal neurons
  • ceramide
  • glucosylceramide
  • ganglioside
  • Gaucher disease
  • Sandhoff disease
  • Niemann-Pick disease